Cart summary

You have no items in your shopping cart.

AWD12−281

SKU: orb1986975

Description

AWD12-281 is a selective phosphodiesterase 4 (PDE4) inhibitor used in biochemical research. It serves as a tool compound for studying PDE4's role in cellular signaling, inflammation, and neurological processes in both in vitro and in vivo experimental models.

Images & Validation

Key Properties

MW443.26
FormulaC22H13Cl2FN2O3
SMILESOC1=CC=C2C(C(C(C(C3=C(Cl)C=NC=C3Cl)=O)=O)=CN2CC4=CC=C(F)C=C4)=C1
TargetOthers

Storage & Handling

Storage-20°C
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Similar Products

  • AWD 12-281 [orb1698258]

    99.85%

    257892-33-4

    458.27

    C22H14Cl2FN3O3

    5 mg, 25 mg, 1 mg, 10 mg, 50 mg
  • AWD12-281 sodium [orb1739865]

    247584-21-0

    480.25

    C22H13Cl2FN3NaO3

    50 mg, 100 mg, 25 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Key Properties

No computed properties available.

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

AWD12−281 (orb1986975)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%